Showing results (91-100 of 308) with videos related to

Sort By:
Pageof 31
Journal of Clinical Epidemiology|June 2, 2021
Methodology over metrics: current scientific standards are a disservice to patients and societyBen Van Calster, Laure Wynants, Richard D Riley, et al.
Research Synthesis Methods|July 24, 2024
Calculating the power of a planned individual participant data meta-analysis to examine prognostic factor effects for a binary outcomeRebecca Whittle, Joie Ensor, Miriam Hattle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neckSankalap Tandon, Catrin Tudur-Smith, Richard D Riley, et al.
BMC Medical Research Methodology|May 20, 2018
Simulation-based power calculations for planning a two-stage individual participant data meta-analysisJoie Ensor, Danielle L Burke, Kym I E Snell, et al.
Diagnostic and Prognostic Research|October 14, 2025
Calibration of cause-specific absolute risk for external validation using each cause-specific hazards model in the presence of competing eventsSarwar I Mozumder, Sarah Booth, Richard D Riley, et al.
Plos One|August 24, 2016
The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast CancerJingjing Liu, Anieta M Sieuwerts, Maxime P Look, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistanceTon van Agthoven, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Cancer Research|August 17, 2002
Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424)Nadia Harbeck, Ronald E Kates, Maxime P Look, et al.
Breast Cancer Research : BCR|August 19, 2007
GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patientsDjura Piersma, Axel P N Themmen, Maxime P Look, et al.
Molecular Oncology|August 6, 2016
LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcomeDiana E Ramirez-Ardila, Kirsten Ruigrok-Ritstier, Jean C Helmijr, et al.
Pageof 31